Dimensional Fund Advisors LP Axcella Health Inc. Transaction History

Dimensional Fund Advisors LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	BUY	$1.62 - $2.73 $35,651 - $60,079	22,007 Added 24.16%	113,085 $194,000
Q1 2022 May 13, 2022	SELL	$1.58 - $2.82 $9,219 - $16,454	-5,835 Reduced 6.02%	91,078 $234,000
Q4 2021 Feb 09, 2022	BUY	$2.06 - $3.61 $13,264 - $23,244	6,439 Added 7.12%	96,913 $202,000
Q3 2021 Nov 12, 2021	SELL	$2.98 - $4.31 $80,367 - $116,236	-26,969 Reduced 22.96%	90,474 $270,000
Q2 2021 Aug 12, 2021	SELL	$3.08 - $5.13 $21,076 - $35,104	-6,843 Reduced 5.51%	117,443 $471,000
Q1 2021 May 14, 2021	BUY	$4.55 - $6.72 $192,979 - $285,015	42,413 Added 51.8%	124,286 $591,000
Q4 2020 Feb 25, 2021	BUY	$4.24 - $5.97 $347,141 - $488,781	81,873 New	81,873 $425,000

61.6K

Ticker AXLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,500,896
Description
Axcella Health Inc. operates as a clinical stage biotechnology company in the United States. The company treats complex diseases and enhances health using endogenous metabolic modulator compositions. Its lead product candidates include AXA1665, which is in Phase 2 clinical trial for the reduction in risk of overt hepatic encephalopathy recurrenc...

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Dimensional Fund Advisors LP with notifications on news.